Pentoxifylline Chew Treat
Pentoxifylline is a compounded formulation containing Pentoxifylline, prepared by Mixlab for veterinary use. Available by prescription.
Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider pentoxifylline in the context of dermatological conditions associated with vasculitis or impaired blood flow. It is frequently a point of discussion for dogs with dermatomyositis, ear margin seborrhea or other immune-mediated skin disorders. In equine practice, it has been evaluated for use in the context of inflammatory conditions affecting the hoof, such as laminitis, as well as endotoxemia. By influencing the physical characteristics of blood and the activity of certain inflammatory cells, your veterinarian can manage the physiological environment of the small blood vessels and surrounding tissues.At a pharmacological level, pentoxifylline acts as a hemorheologic agent by increasing the flexibility of red blood cells (erythrocytes) and decreasing blood viscosity. This is achieved by inhibiting the enzyme phosphodiesterase, which leads to increased levels of cyclic AMP within the cells. Additionally, pentoxifylline is studied for its ability to inhibit the production of Tumor Necrosis Factor-alpha (TNF-α) and other pro-inflammatory cytokines, which shapes its profile as a mild immunomodulator. These mechanisms allow for better oxygen delivery to peripheral tissues and a reduction in localized tissue damage. Your veterinarian will determine the appropriate delivery method and duration of use based on your pet’s weight, species and the specific clinical nature of the vascular or inflammatory challenge.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects of pentoxifylline include gastrointestinal changes such as vomiting, decreased appetite or loose stools. Some animals may exhibit mild central nervous system stimulation, characterized by restlessness or a temporary increase in heart rate. Because pentoxifylline is a methylxanthine derivative, your veterinarian will monitor for signs of sensitivity, especially in patients already receiving other medications in this class. Owners should monitor for any unusual bleeding or bruising, although these effects are less frequently noted. If you observe significant behavioral changes, persistent gastrointestinal upset or signs of physical distress, contact your veterinarian promptly.This medication is typically used with caution in patients with known kidney or liver impairment, as these organs are involved in the metabolic processing and elimination of the medication. It is also carefully evaluated in animals with a history of significant cardiovascular disease or those with a known sensitivity to caffeine or theobromine. Before starting a protocol involving pentoxifylline, ensure your veterinarian has a complete history of all other prescriptions and supplements your pet is receiving, as it may interact with anticoagulants or certain antibiotics. Your veterinarian is the right person to design a comprehensive management approach and determine the timing of any necessary follow-up examinations to ensure the protocol remains suitable for your pet's needs.
Yes. Pentoxifylline is a prescription medication and can only be dispensed by a licensed pharmacy like Mixlab upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all prescriptions before any medication is prepared or sent to your home or stable.
Yes. While pentoxifylline is available in some commercial tablet formats, Mixlab can compound this medication into specialized strengths or flavored dosage forms—such as flavored oral liquids or chews—if your veterinarian determines a customized preparation is necessary for your pet. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians discuss pentoxifylline for certain skin issues because it may be considered in the context of supporting blood flow to the very small vessels at the skin's surface. By making red blood cells more flexible and reducing inflammation, it is considered as part of a management approach for conditions where blood supply to the skin is compromised.
Owners should monitor for signs of digestive upset, such as vomiting or a change in appetite, as well as changes in energy or heart rate. It is important to report any persistent restlessness or gastrointestinal signs to your veterinarian to ensure the management plan remains appropriate for your pet’s individual health status.
